Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents
Introduction Depressive disorders in adolescents are highly prevalent and debilitating and are a risk factor for self-harm and death by suicide. In the context of recovery from the COVID-19 pandemic, strained healthcare resources are compounded by an increased demand for treatment services for adole...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/5/e092541.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849725392177332224 |
|---|---|
| author | Peter Szatmari Claire de Oliveira Darren Courtney Jo Henderson Joyce Mason Bahar Amani Gray Liddell |
| author_facet | Peter Szatmari Claire de Oliveira Darren Courtney Jo Henderson Joyce Mason Bahar Amani Gray Liddell |
| author_sort | Peter Szatmari |
| collection | DOAJ |
| description | Introduction Depressive disorders in adolescents are highly prevalent and debilitating and are a risk factor for self-harm and death by suicide. In the context of recovery from the COVID-19 pandemic, strained healthcare resources are compounded by an increased demand for treatment services for adolescents with depression. The objective of this study protocol is to delineate the proposed economic evaluation of an integrated care pathway for depression in adolescents within the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial.Methods and analysis Two economic evaluations of the CARIBOU-2 trial (n=300) will be conducted—a cost-effectiveness analysis and a cost-utility analysis. In the cost-effectiveness analysis, we will examine the primary clinical outcome of the trial, change in the Mood and Feelings Questionnaire total score. In the cost-utility analysis, the clinical outcome will be quality-adjusted life-years, a generic measure of health burden. Data on the resources and respective costs required to deliver the intervention will be collected by the research team. Data on resource use post-intervention will be obtained from a mix of administrative data holdings and self-report; relevant unit costs will be obtained from existing data sources. The outcome of both economic evaluations will be the incremental cost-effectiveness ratio. Relevant sensitivity analyses will be undertaken, and cost-effectiveness acceptability curves will be produced to characterise any sources of uncertainty in the analysis. Equity considerations will also be examined, where relevant.Ethics and dissemination Ethical approval for the larger CARIBOU-2 trial, including the economic evaluation, has been obtained by the Centre for Addiction and Mental Health as well as site-level ethics boards (019/2021; Centre for Addiction and Mental Health). All participants will provide informed consent for their data to be analysed and reported. The results of the main trial and the economic evaluation will be submitted for publication in a peer-reviewed journal and shared with relevant policy makers across Canada.Trial registration number NCT05142683. |
| format | Article |
| id | doaj-art-4d692c0e12484455806fb8ad5368679f |
| institution | DOAJ |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-4d692c0e12484455806fb8ad5368679f2025-08-20T03:10:28ZengBMJ Publishing GroupBMJ Open2044-60552025-05-0115510.1136/bmjopen-2024-092541Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescentsPeter Szatmari0Claire de Oliveira1Darren Courtney2Jo Henderson3Joyce Mason4Bahar Amani5Gray Liddell6Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaCundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto, Ontario, CanadaInstitute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaCundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaCundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Toronto, Ontario, CanadaIntroduction Depressive disorders in adolescents are highly prevalent and debilitating and are a risk factor for self-harm and death by suicide. In the context of recovery from the COVID-19 pandemic, strained healthcare resources are compounded by an increased demand for treatment services for adolescents with depression. The objective of this study protocol is to delineate the proposed economic evaluation of an integrated care pathway for depression in adolescents within the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial.Methods and analysis Two economic evaluations of the CARIBOU-2 trial (n=300) will be conducted—a cost-effectiveness analysis and a cost-utility analysis. In the cost-effectiveness analysis, we will examine the primary clinical outcome of the trial, change in the Mood and Feelings Questionnaire total score. In the cost-utility analysis, the clinical outcome will be quality-adjusted life-years, a generic measure of health burden. Data on the resources and respective costs required to deliver the intervention will be collected by the research team. Data on resource use post-intervention will be obtained from a mix of administrative data holdings and self-report; relevant unit costs will be obtained from existing data sources. The outcome of both economic evaluations will be the incremental cost-effectiveness ratio. Relevant sensitivity analyses will be undertaken, and cost-effectiveness acceptability curves will be produced to characterise any sources of uncertainty in the analysis. Equity considerations will also be examined, where relevant.Ethics and dissemination Ethical approval for the larger CARIBOU-2 trial, including the economic evaluation, has been obtained by the Centre for Addiction and Mental Health as well as site-level ethics boards (019/2021; Centre for Addiction and Mental Health). All participants will provide informed consent for their data to be analysed and reported. The results of the main trial and the economic evaluation will be submitted for publication in a peer-reviewed journal and shared with relevant policy makers across Canada.Trial registration number NCT05142683.https://bmjopen.bmj.com/content/15/5/e092541.full |
| spellingShingle | Peter Szatmari Claire de Oliveira Darren Courtney Jo Henderson Joyce Mason Bahar Amani Gray Liddell Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents BMJ Open |
| title | Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents |
| title_full | Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents |
| title_fullStr | Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents |
| title_full_unstemmed | Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents |
| title_short | Protocol for the economic evaluation of the Care for Adolescents who Received Information ‘Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents |
| title_sort | protocol for the economic evaluation of the care for adolescents who received information bout outcomes 2nd iteration caribou 2 non randomised cluster controlled trial of an integrated care pathway for depression in adolescents |
| url | https://bmjopen.bmj.com/content/15/5/e092541.full |
| work_keys_str_mv | AT peterszatmari protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT clairedeoliveira protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT darrencourtney protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT johenderson protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT joycemason protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT baharamani protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents AT grayliddell protocolfortheeconomicevaluationofthecareforadolescentswhoreceivedinformationboutoutcomes2nditerationcaribou2nonrandomisedclustercontrolledtrialofanintegratedcarepathwayfordepressioninadolescents |